The multiple roles of amphiregulin in human cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1816, Issue 2, 2011, Pages 119-131

  Busser, Benoit ^a,b,c   Sancey, Lucie ^a,b   Brambilla, Elisabeth ^a,b,c   Coll, Jean Luc ^a,b   Hurbin, Amandine ^a,b  

^a INSTITUT ALBERT BONNIOT   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

Amphiregulin; Angiogenesis; Biomarker; Cancer; Epidermal growth factor receptor tyrosine; Kinase inhibitor; Metastasis

Indexed keywords

AMPHIREGULIN; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; TRASTUZUMAB; TUMOR MARKER;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER CONTROL; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CARCINOGENESIS; CHEMOSENSITIVITY; COLORECTAL CANCER; HEAD AND NECK CARCINOMA; HUMAN; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METASTASIS; METASTASIS POTENTIAL; MONOTHERAPY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 79959255967     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.05.003     Document Type: Review

References (200)

1. M. Shoyab, V.L. McDonald, J.G. Bradley, G.J. Todaro, Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6528-6532.
2. H. Kimura, W.H. Fischer, D. Schubert, Structure, expression and function of a schwannoma-derived growth factor, Nature 348 (1990) 257-260.
3. C.L. Brown, K.S. Meise, G.D. Plowman, R.J. Coffey, P.J. Dempsey, Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form, J. Biol. Chem. 273 (1998) 17258-17268.
4. M.J. Duffy, E. McKiernan, N. O'Donovan, P.M. McGowan, Role of ADAMs in cancer formation and progression, Clin. Cancer Res. 15 (2009) 1140-1144.
5. N.C. Luetteke, T.H. Qiu, S.E. Fenton, K.L. Troyer, R.F. Riedel, A. Chang, D.C. Lee, Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development, Development 126 (1999) 2739-2750.
6. M. Shoyab, G.D. Plowman, V.L. McDonald, J.G. Bradley, G.J. Todaro, Structure and function of human amphiregulin: a member of the epidermal growth factor family, Science 243 (1989) 1074-1076.
7. Y. Yarden, M.X. Sliwkowski, Untangling the ErbB signalling network, Nat. Rev. Mol. Cell Biol. 2 (2001) 127-137.
8. A. Citri, Y. Yarden, EGF-ERBB signalling: towards the systems level, Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516.
9. M.A. Olayioye, R.M. Neve, H.A. Lane, N.E. Hynes, The ErbB signaling network: receptor heterodimerization in development and cancer, EMBO J. 19 (2000) 3159-3167.
10. T. Holbro, G. Civenni, N.E. Hynes, The ErbB receptors and their role in cancer progression, Exp. Cell Res. 284 (2003) 99-110.
11. R.R. Beerli, N.E. Hynes, Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities, J. Biol. Chem. 271 (1996) 6071-6076.
12. J.A. Barnard, R. Graves-Deal, M.R. Pittelkow, R. DuBois, P. Cook, G.W. Ramsey, P.R. Bishop, L. Damstrup, R.J. Coffey, Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family, J. Biol. Chem. 269 (1994) 22817-22822.
13. N. Normanno, A. De Luca, C. Bianco, L. Strizzi, M. Mancino, M.R. Maiello, A. Carotenuto, G. De Feo, F. Caponigro, D.S. Salomon, Epidermal growth factor receptor (EGFR) signaling in cancer, Gene 366 (2006) 2-16.
14. K.E. Longva, F.D. Blystad, E. Stang, A.M. Larsen, L.E. Johannessen, I.H. Madshus, Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies, J. Cell Biol. 156 (2002) 843-854.
15. K.A. Stern, T.L. Place, N.L. Lill, EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate, Biochem. J. 410 (2008) 585-594.
16. A. Baldys, M. Gooz, T.A. Morinelli, M.H. Lee, J.R. Raymond Jr., L.M. Luttrell, J.R. Raymond Sr., Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor, Biochemistry 48 (2009) 1462-1473.
17. N.E. Willmarth, A. Baillo, M.L. Dziubinski, K. Wilson, D.J. Riese II, S.P. Ethier, Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop, Cell. Signal. 21 (2009) 212-219.
18. A.B. Singh, R.C. Harris, Autocrine, paracrine and juxtacrine signaling by EGFR ligands, Cell. Signal. 17 (2005) 1183-1193.
19. M.R. Schneider, E. Wolf, The epidermal growth factor receptor ligands at a glance, J. Cell. Physiol. 218 (2009) 460-466.
20. S. Li, G.D. Plowman, S.D. Buckley, G.D. Shipley, Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells, J. Cell. Physiol. 153 (1992) 103-111.
21. M.D. Sternlicht, S.W. Sunnarborg, H. Kouros-Mehr, Y. Yu, D.C. Lee, Z. Werb, Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin, Development 132 (2005) 3923-3933.
22. N.E. Willmarth, S.P. Ethier, Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells, J. Biol. Chem. 281 (2006) 37728-37737.
23. A.A. Brandes, E. Franceschi, A. Tosoni, M.E. Hegi, R. Stupp, Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments, Clin. Cancer Res. 14 (2008) 957-960.
24. O. Inatomi, A. Andoh, Y. Yagi, S. Bamba, T. Tsujikawa, Y. Fujiyama, Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts, Int. J. Mol. Med. 18 (2006) 497-503.
25. C. Berasain, E.R. Garcia-Trevijano, J. Castillo, E. Erroba, D.C. Lee, J. Prieto, M.A. Avila, Amphiregulin: an early trigger of liver regeneration in mice, Gastroenterology 128 (2005) 424-432.
26. A. Gschwind, S. Hart, O.M. Fischer, A. Ullrich, TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells, EMBO J. 22 (2003) 2411-2421.
27. G.D. Plowman, J.M. Green, V.L. McDonald, M.G. Neubauer, C.M. Disteche, G.J. Todaro, M. Shoyab, The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity, Mol. Cell. Biol. 10 (1990) 1969-1981.
28. C. Berasain, E.R. Garcia-Trevijano, J. Castillo, E. Erroba, M. Santamaria, D.C. Lee, J. Prieto, M.A. Avila, Novel role for amphiregulin in protection from liver injury, J. Biol. Chem. 280 (2005) 19012-19020.
29. L. Ciarloni, S. Mallepell, C. Brisken, Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development, Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 5455-5460.
30. E.C. Tsark, E.D. Adamson, G.E. Withers III, L.M. Wiley, Expression and function of amphiregulin during murine preimplantation development, Mol. Reprod. Dev. 47 (1997) 271-283.
31. A. Kariagina, J. Xie, J.R. Leipprandt, S.Z. Haslam, Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers, Horm Cancer 1 (2010) 229-244.
32. S. Lee, D. Medina, A. Tsimelzon, S.K. Mohsin, S. Mao, Y. Wu, D.C. Allred, Alterations of gene expression in the development of early hyperplastic precursors of breast cancer, Am. J. Pathol. 171 (2007) 252-262.
33. K. Ejskjaer, B.S. Sorensen, S.S. Poulsen, O. Mogensen, A. Forman, E. Nexo, Expression of the epidermal growth factor system in human endometrium during the menstrual cycle, Mol. Hum. Reprod. 11 (2005) 543-551.
34. J.R. Sherwin, T.C. Freeman, R.J. Stephens, S. Kimber, A.G. Smith, I. Chambers, S.K. Smith, A.M. Sharkey, Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation, Mol. Endocrinol. 18 (2004) 2185-2195.
35. H. Song, H. Lim, S.K. Das, B.C. Paria, S.K. Dey, Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice, Mol. Endocrinol. 14 (2000) 1147-1161.
36. S.K. Das, I. Chakraborty, B.C. Paria, X.N. Wang, G. Plowman, S.K. Dey, Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus, Mol. Endocrinol. 9 (1995) 691-705.
37. D.S. Lee, Y. Yanagimoto Ueta, H. Suzuki, Expression of amphiregulin during the pre- and post-implantation period in the mouse reproductive tract, J. Reprod. Dev. 52 (2006) 781-787.
38. J. Reese, N. Binart, N. Brown, W.G. Ma, B.C. Paria, S.K. Das, P.A. Kelly, S.K. Dey, Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR, Endocrinology 141 (2000) 1872-1881.
39. J.Y. Park, Y.Q. Su, M. Ariga, E. Law, S.L. Jin, M. Conti, EGF-like growth factors as mediators of LH action in the ovulatory follicle, Science 303 (2004) 682-684.
40. N. Torring, B.S. Sorensen, S.T. Bosch, H. Klocker, E. Nexo, Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue, Prostate Cancer Prostatic Dis. 1 (1998) 262-267.
41. S.B. Lee, K. Huang, R. Palmer, V.B. Truong, D. Herzlinger, K.A. Kolquist, J. Wong, C. Paulding, S.K. Yoon, W. Gerald, J.D. Oliner, D.A. Haber, The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin, Cell 98 (1999) 663-673.
42. H. Sakurai, T. Tsukamoto, C.A. Kjelsberg, L.G. Cantley, S.K. Nigam, EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney, Am. J. Physiol. 273 (1997) F463-472.
43. L. Schuger, G.R. Johnson, K. Gilbride, G.D. Plowman, R. Mandel, Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation, Development 122 (1996) 1759-1767.
44. C. Berasain, J. Castillo, M.J. Perugorria, J. Prieto, M.A. Avila, Amphiregulin: a new growth factor in hepatocarcinogenesis, Cancer Lett. 254 (2007) 30-41.
45. K. Shiraishi, H. Matsuyama, Local expression of epidermal growth factor-like growth factors in human testis and its role in spermatogenesis, J. Androl. (2011).
46. L. Qin, J. Tamasi, L. Raggatt, X. Li, J.H. Feyen, D.C. Lee, E. Dicicco-Bloom, N.C. Partridge, Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation, J. Biol. Chem. 280 (2005) 3974-3981.
47. L. Qin, N.C. Partridge, Stimulation ofa mphiregulin expression in osteoblastic cells by parathyroid hormone requires the protein kinase A and cAMP response element-binding protein signaling pathway, J. Cell. Biochem. 96 (2005) 632-640.
48. T. Tondreau, M. Dejeneffe, N. Meuleman, B. Stamatopoulos, A. Delforge, P. Martiat, D. Bron, L. Lagneaux, Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells, BMC Genomics 9 (2008) 166.
49. A. Falk, J. Frisen, Amphiregulin is a mitogen for adult neural stem cells, J. Neurosci. Res. 69 (2002) 757-762.
50. A. Nilsson, K. Moller, L. Dahlin, G. Lundborg, M. Kanje, Early changes in gene expression in the dorsal root ganglia after transection of the sciatic nerve; effects of amphiregulin and PAI-1 on regeneration, Brain Res. Mol. Brain Res. 136 (2005) 65-74.
51. L. Rittie, J. Varani, S. Kang, J.J. Voorhees, G.J. Fisher, Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo, J. Invest. Dermatol. 126 (2006) 732-739.
52. N. Normanno, F. Ciardiello, R. Brandt, D.S. Salomon, Epidermal growth factor-related peptides in the pathogenesis of human breast cancer, Breast Cancer Res. Treat. 29 (1994) 11-27.
53. M.J. Perugorria, M.U. Latasa, A. Nicou, H. Cartagena-Lirola, J. Castillo, S. Goni, U. Vespasiani-Gentilucci, M.G. Zagami, S. Lotersztajn, J. Prieto, C. Berasain, M.A. Avila, The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis, Hepatology 48 (2008) 1251-1261.
54. G.D. Richardson, H. Bazzi, K.A. Fantauzzo, J.M. Waters, H. Crawford, P. Hynd, A.M. Christiano, C.A. Jahoda, KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin, Development 136 (2009) 2153-2164.
55. P.W. Cook, P.A. Mattox, W.W. Keeble, M.R. Pittelkow, G.D. Plowman, M. Shoyab, J.P. Adelman, G.D. Shipley, A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin, Mol. Cell. Biol. 11 (1991) 2547-2557.
56. E. Chung, P.W. Cook, C.A. Parkos, Y.K. Park, M.R. Pittelkow, R.J. Coffey, Amphiregulin causes functional downregulation of adherens junctions in psoriasis, J. Invest. Dermatol. 124 (2005) 1134-1140.
57. S.W. Stoll, J.L. Johnson, Y. Li, L. Rittie, J.T. Elder, Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth, J Invest Dermatol, 130 2031-2040.
58. D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation, Cell 144 (2011) 646-674.
59. J. McBryan, J. Howlin, S. Napoletano, F. Martin, Amphiregulin: role in mammary gland development and breast cancer, J. Mammary Gland Biol. Neoplasia 13 (2008) 159-169.
60. N. Eckstein, K. Servan, L. Girard, D. Cai, G. von Jonquieres, U. Jaehde, M.U. Kassack, A.F. Gazdar, J.D. Minna, H.D. Royer, Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells, J. Biol. Chem. 283 (2008) 739-750.
61. C.L. Addison, K. Ding, H. Zhao, A. Le Maitre, G.D. Goss, L. Seymour, M.S. Tsao, F.A. Shepherd, P.A. Bradbury, Plasma transforming growth factor {alpha} and amphiregulin protein levels in NCIC Clinical Trials Group BR.21, J. Clin. Oncol. (2010).
62. N. Ishikawa, Y. Daigo, A. Takano, M. Taniwaki, T. Kato, S. Hayama, H. Murakami, Y. Takeshima, K. Inai, H. Nishimura, E. Tsuchiya, N. Kohno, Y. Nakamura, Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers, Cancer Res. 65 (2005) 9176-9184.
63. D. Hanahan, R.A. Weinberg, The hallmarks of cancer, Cell 100 (2000) 57-70.
64. N. Normanno, M.P. Selvam, C.F. Qi, T. Saeki, G. Johnson, N. Kim, F. Ciardiello, M. Shoyab, G. Plowman, R. Brandt, et al., Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2790-2794.
65. I.M. Berquin, M.L. Dziubinski, G.P. Nolan, S.P. Ethier, A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin, Oncogene 20 (2001) 4019-4028.
66. J. Castillo, E. Erroba, M.J. Perugorria, M. Santamaria, D.C. Lee, J. Prieto, M.A. Avila, C. Berasain, Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells, Cancer Res. 66 (2006) 6129-6138.
67. A. Hurbin, L. Dubrez, J.L. Coll, M.C. Favrot, Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines, J. Biol. Chem. 277 (2002) 49127-49133.
68. G.R. Johnson, T. Saeki, A.W. Gordon, M. Shoyab, D.S. Salomon, K. Stromberg, Autocrine action of amphiregulin in a colon carcinoma cell line and immuno-cytochemical localization of amphiregulin in human colon, J. Cell Biol. 118 (1992) 741-751.
69. I. Zvibel, S. Brill, Z. Halpern, M. Papa, Amphiregulin and hepatocyte-derived extracellular matrix regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capability, J. Cell. Biochem. 76 (1999) 332-340.
70. M. Kato, T. Inazu, Y. Kawai, K. Masamura, M. Yoshida, N. Tanaka, K. Miyamoto, I. Miyamori, Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5, Biochem. Biophys. Res. Commun. 301 (2003) 1109-1115.
71. L. Ma, C. Gauville, Y. Berthois, G. Millot, G.R. Johnson, F. Calvo, Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line, Oncogene 18 (1999) 6513-6520.
72. H. Funatomi, J. Itakura, T. Ishiwata, I. Pastan, S.A. Thompson, G.R. Johnson, M. Korc, Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy, Int. J. Cancer 72 (1997) 512-517.
73. T. Saeki, K. Stromberg, C.F. Qi, W.J. Gullick, E. Tahara, N. Normanno, F. Ciardiello, N. Kenney, G.R. Johnson, D.S. Salomon, Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors, Cancer Res. 52 (1992) 3467-3473.
74. S. LeJeune, R. Leek, E. Horak, G. Plowman, M. Greenall, A.L. Harris, Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer, Cancer Res. 53 (1993) 3597-3602.
75. L. Panico, A. D'Antonio, G. Salvatore, E. Mezza, G. Tortora, M. De Laurentiis, S. De Placido, T. Giordano, M. Merino, D.S. Salomon, W.J. Mullick, G. Pettinato, S.J. Schnitt, A.R. Bianco, F. Ciardiello, Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues, Int. J. Cancer 65 (1996) 51-56.
76. J. Dong, L.K. Opresko, P.J. Dempsey, D.A. Lauffenburger, R.J. Coffey, H.S. Wiley, Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor, Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6235-6240.
77. S.W. Stoll, J.L. Johnson, Y. Li, L. Rittie, J.T. Elder, Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth, J. Invest. Dermatol. 130 (2010) 2031-2040.
78. C. Bavik, I. Coleman, J.P. Dean, B. Knudsen, S. Plymate, P.S. Nelson, The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms, Cancer Res. 66 (2006) 794-802.
79. Y. Lemos-Gonzalez, F.J. Rodriguez-Berrocal, O.J. Cordero, C. Gomez, M. Paez de la Cadena, Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma, Br. J. Cancer 96 (2007) 1569-1578.
80. A. Murthy, V. Defamie, D.S. Smookler, M.A. Di Grappa, K. Horiuchi, M. Federici, M. Sibilia, C.P. Blobel, R. Khokha, Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice, J. Clin. Invest. 120 (2010) 2731-2744.
81. A. Hurbin, J.L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, M.C. Favrot, Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells, J. Biol. Chem. 280 (2005) 19757-19767.
82. M. Lorente, A. Carracedo, S. Torres, F. Natali, A. Egia, S. Hernandez-Tiedra, M. Salazar, C. Blazquez, M. Guzman, G. Velasco, Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis, Glia 57 (2009) 1374-1385.
83. L. Hayflick, Mortality and immortality at the cellular level. A review, Biochemistry (Mosc) 62 (1997) 1180-1190.
84. M. Matsui, J. Miyasaka, K. Hamada, Y. Ogawa, M. Hiramoto, R. Fujimori, A. Aioi, Influence of aging and cell senescence on telomerase activity in keratinocytes, J. Dermatol. Sci. 22 (2000) 80-87.
85. A.S. Chung, J. Lee, N. Ferrara, Targeting the tumour vasculature: insights from physiological angiogenesis, Nat. Rev. Cancer 10 (2010) 505-514.
86. C.W. Pugh, P.J. Ratcliffe, Regulation of angiogenesis by hypoxia: role of the HIF system, Nat. Med. 9 (2003) 677-684.
87. J. Pouyssegur, F. Dayan, N.M. Mazure, Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature 441 (2006) 437-443.
88. G.L. Semenza, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer 3 (2003) 721-732.
89. N. Ferrara, VEGF and the quest for tumour angiogenesis factors, Nat. Rev. Cancer 2 (2002) 795-803.
90. M.R. Bordoli, D.P. Stiehl, L. Borsig, G. Kristiansen, S. Hausladen, P. Schraml, R.H. Wenger, G. Camenisch, Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis, Oncogene (2010).
91. D.A. Chan, T.L. Kawahara, P.D. Sutphin, H.Y. Chang, J.T. Chi, A.J. Giaccia, Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment, Cancer Cell 15 (2009) 527-538.
92. D.A. Chan, A.J. Giaccia, PHD2 in tumour angiogenesis, Br. J. Cancer 103 (2010) 1-5.
93. M. Mazzone, D. Dettori, R. Leite de Oliveira, S. Loges, T. Schmidt, B. Jonckx, Y.M. Tian, A.A. Lanahan, P. Pollard, C. Ruiz de Almodovar, F. De Smet, S. Vinckier, J. Aragones, K. Debackere, A. Luttun, S. Wyns, B. Jordan, A. Pisacane, B. Gallez, M.G. Lampugnani, E. Dejana, M. Simons, P. Ratcliffe, P. Maxwell, P. Carmeliet, Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization, Cell 136 (2009) 839-851.
94. C. Giusti, S. Desruisseau, L. Ma, F. Calvo, P.M. Martin, Y. Berthois, Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells, Int. J. Cancer 105 (2003) 769-778.
95. G.T. Wagenaar, S.A. ter Horst, M.A. van Gastelen, L.M. Leijser, T. Mauad, P.A. van der Velden, E. de Heer, P.S. Hiemstra, B.J. Poorthuis, F.J. Walther, Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress, Free Radic. Biol. Med. 36 (2004) 782-801.
96. S.M. O'Reilly, M.O. Leonard, N. Kieran, K.M. Comerford, E. Cummins, M. Pouliot, S.B. Lee, C.T. Taylor, Hypoxia induces epithelial amphiregulin gene expression in a CREB-dependent manner, Am. J. Physiol. Cell Physiol. 290 (2006) C592-600.
97. T.H. Hung, S.F. Chen, C.C. Hsieh, J.J. Hsu, M.J. Li, Y.L. Yeh, T.T. Hsieh, Tumor necrosis factor-alpha converting enzyme in the human placenta throughout gestation, Reprod. Sci. 15 (2008) 195-209.
98. K. Deacon, A.J. Knox, Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop, J. Biol. Chem. 285 (2010) 25913-25927.
99. T. Hayashida, F. Takahashi, N. Chiba, E. Brachtel, M. Takahashi, N. Godin-Heymann, K.W. Gross, M.M. Vivanco, V. Wijendran, T. Shioda, D. Sgroi, P.K. Donahoe, S. Maheswaran, HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis, Proc. Natl. Acad. Sci. U.S.A. 107 (2010) 1100-1105.
100. J. Shao, S.B. Lee, H. Guo, B.M. Evers, H. Sheng, Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin, Cancer Res. 63 (2003) 5218-5223.
101. N.E. Willmarth, S.P. Ethier, Amphiregulin as a novel target for breast cancer therapy, J. Mammary Gland Biol. Neoplasia 13 (2008) 171-179.
102. M. Silvy, C. Giusti, P.M. Martin, Y. Berthois, Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells, Br. J. Cancer 84 (2001) 936-945.
103. F. Ciardiello, N. Kim, T. Saeki, R. Dono, M.G. Persico, G.D. Plowman, J. Garrigues, S. Radke, G.J. Todaro, D.S. Salomon, Differential expression of epidermal growth factor-related proteins in human colorectal tumors, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7792-7796.
104. V. Picihard, Y. Berthois, M. Roccabianca, C. Prevot, M. Sarrazin, H. Portugal, S. Kumar, P. Kumar, J.B. Rognoni, Concomitant cell growth and differentiation are dependent on erbB1 and integrin activation in an autonomously surviving colon adenocarcinoma: involvement of autocrine amphiregulin secretion, Anticancer Res. 26 (2006) 2769-2783.
105. O.c. P, H. Modjtahedi, P. Rhys-Evans, W.J. Court, G.M. Box, S.A. Eccles, Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells, Cancer Res. 60 (2000) 1121-1128.
106. S. Menashi, M. Serova, L. Ma, S. Vignot, S. Mourah, F. Calvo, Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells, Cancer Res. 63 (2003) 7575-7580.
107. S.B. Kondapaka, R. Fridman, K.B. Reddy, Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells, Int. J. Cancer 70 (1997) 722-726.
108. Z. Liu, J. Klominek, Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors, Thorax 58 (2003) 198-203.
109. M.A. Huber, N. Kraut, H. Beug, Molecular requirements for epithelial-mesenchymal transition during tumor progression, Curr. Opin. Cell Biol. 17 (2005) 548-558.
110. A. Rohrbeck, J. Borlak, Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1, PLoS One 4 (2009) e7315.
111. Q.Q. Li, Z.Q. Chen, X.X. Cao, J.D. Xu, J.W. Xu, Y.Y. Chen, W.J. Wang, Q. Chen, F. Tang, X.P. Liu, Z.D. Xu, Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells, Cell Death Differ. (2010).
112. J. Zhang, J.Y. Ji, M. Yu, M. Overholtzer, G.A. Smolen, R. Wang, J.S. Brugge, N.J. Dyson, D.A. Haber, YAP-dependent induction of amphiregulin identifies a non- cell-autonomous component of the Hippo pathway, Nat. Cell Biol. 11 (2009) 1444-1450.
113. R.M. Adam, S.G. Chamberlin, D.E. Davies, Induction of anchorage-independent growth by amphiregulin, Growth Factors 13 (1996) 193-203.
114. N. Normanno, M.P. Selvam, C. Bianco, V. Damiano, E. de Angelis, M. Grassi, G. Magliulo, G. Tortora, D.S. Salomon, F. Ciardiello, Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line, Int. J. Cancer 62 (1995) 762-766.
115. N. Tarbe, S. Losch, H. Burtscher, M. Jarsch, U.H. Weidle, Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis, Anti-cancer Res. 22 (2002) 2015-2027.
116. T. Watanabe, T. Kobunai, Y. Yamamoto, T. Kanazawa, T. Konishi, T. Tanaka, K. Matsuda, S. Ishihara, K. Nozawa, K. Eshima, T. Muto, H. Nagawa, Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes, Eur. J. Cancer 46 (2010) 2119-2126.
117. X.D. Li, S.Y. Miao, G.L. Wang, L. Yang, Y.Q. Shu, Y.M. Yin, Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics, Onkologie 33 (2010) 353-358.
118. M. Sun, C. Behrens, L. Feng, N. Ozburn, X. Tang, G. Yin, R. Komaki, M. Varella-Garcia, W.K. Hong, K.D. Aldape, Wistuba II, HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors, Clin. Cancer Res. 15 (2009) 4829-4837.
119. M. Yamada, Y. Ichikawa, S. Yamagishi, N. Momiyama, M. Ota, S. Fujii, K. Tanaka, S. Togo, S. Ohki, H. Shimada, Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer, Clin. Cancer Res. 14 (2008) 2351-2356.
120. K. Ogawa, T. Utsunomiya, K. Mimori, F. Tanaka, N. Haraguchi, H. Inoue, S. Murayama, M. Mori, Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation, Int. J. Oncol. 28 (2006) 705-713.
121. M. Toulany, M. Baumann, H.P. Rodemann, Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity, Mol. Cancer Res. 5 (2007) 863-872.
122. M. Toulany, K. Dittmann, M. Kruger, M. Baumann, H.P. Rodemann, Radio-resistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway, Radiother. Oncol. 76 (2005) 143-150.
123. C.J. Chang, P.H. Yin, D.M. Yang, C.H. Wang, W.Y. Hung, C.W. Chi, Y.H. Wei, H.C. Lee, Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells, Cell. Mol. Life Sci. 66 (2009) 1755-1765.
124. X. Wang, S. Masri, S. Phung, S. Chen, The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop, Cancer Res. 68 (2008) 2259-2265.
125. G. Fontanini, M. De Laurentiis, S. Vignati, S. Chine, M. Lucchi, V. Silvestri, A. Mussi, S. De Placido, G. Tortora, A.R. Bianco, W. Gullick, C.A. Angeletti, G. Bevilacqua, F. Ciardiello, Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival, Clin. Cancer Res. 4 (1998) 241-249.
126. D.W. Visscher, F.H. Sarkar, T.C. Kasunic, K.B. Reddy, Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia, Breast Cancer Res. Treat. 45 (1997) 75-80.
127. D.G. Bostwick, J. Qian, N.J. Maihle, Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases, Prostate 58 (2004) 164-168.
128. M. Ebert, M. Yokoyama, M.S. Kobrin, H. Friess, M.E. Lopez, M.W. Buchler, G.R. Johnson, M. Korc, Induction and expression of amphiregulin in human pancreatic cancer, Cancer Res. 54 (1994) 3959-3962.
129. T. Nishimura, A. Andoh, O. Inatomi, M. Shioya, Y. Yagi, T. Tsujikawa, Y. Fujiyama, Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon, Oncol. Rep. 19 (2008) 105-110.
130. V.B. Thogersen, B.S. Sorensen, S.S. Poulsen, T.F. Orntoft, H. Wolf, E. Nexo, A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients, Cancer Res. 61 (2001) 6227-6233.
131. J. Kleeff, H. Friess, P.O. Berberat, M.E. Martignoni, K. Z'Graggen, M.W. Buchler, Pancreatic cancer-new aspects of molecular biology research, Swiss Surg. 6 (2000) 231-234.
132. A. D'Antonio, S. Losito, S. Pignata, M. Grassi, F. Perrone, A. De Luca, R. Tambaro, C. Bianco, W.J. Gullick, G.R. Johnson, V.R. Iaffaioli, D.S. Salomon, N. Normanno, Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas, Int. J. Oncol. 21 (2002) 941-948.
133. D.S. Salomon, R. Brandt, F. Ciardiello, N. Normanno, Epidermal growth factor-related peptides and their receptors in human malignancies, Crit. Rev. Oncol. Hematol. 19 (1995) 183-232.
134. N.E. Hynes, H.A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat. Rev. Cancer 5 (2005) 341-354.
135. S. Khambata-Ford, C.R. Garrett, N.J. Meropol, M. Basik, C.T. Harbison, S. Wu, T.W. Wong, X. Huang, C.H. Takimoto, A.K. Godwin, B.R. Tan, S.S. Krishnamurthi, H.A. Burris III, E.A. Poplin, M. Hidalgo, J. Baselga, E.A. Clark, D.J. Mauro, Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab, J. Clin. Oncol. 25 (2007) 3230-3237.
136. B. Jacobs, W. De Roock, H. Piessevaux, R. Van Oirbeek, B. Biesmans, J. De Schutter, S. Fieuws, J. Vandesompele, M. Peeters, J.L. Van Laethem, Y. Humblet, F. Penault-Llorca, G. De Hertogh, P. Laurent-Puig, E. Van Cutsem, S. Tejpar, Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab, J. Clin. Oncol. 27 (2009) 5068-5074.
137. C. Oliveras-Ferraros, A.M. Vall-Llovera, D.C. Salip, A. Vazquez-Martin, S. Cufi,B. Queralt, B. Martin-Castillo, J. Brunet, R. de Llorens, J.A. Menendez, Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells, Invest. New Drugs (2010).
138. C. Oliveras-Ferraros, A. Vazquez-Martin, S. Cufi, B. Queralt, L. Baez, R. Guardeno, X. Hernandez-Yague, B. Martin-Castillo, J. Brunet, J.A. Menendez, The stem cell property epithelial-to-mesenchymal transition (EMT) is a core transcriptional network for predicting cetuximab (Erbitux) efficacy in KRAS wild-type tumor cells, J Cell Biochem (2010).
139. J.B. Baker, D. Dutta, D. Watson, T. Maddala, B.M. Munneke, S. Shak, E.K. Rowinsky, L.A. Xu, C.T. Harbison, E.A. Clark, D.J. Mauro, S. Khambata-Ford, Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer, Br. J. Cancer 104 (2011) 488-495.
140. R. Krumbach, J. Schuler, M. Hofmann, T. Giesemann, H.H. Fiebig, T. Beckers, Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance, Eur. J. Cancer (2011).
141. S.J. Rogers, C. Box, P. Chambers, Y. Barbachano, C.M. Nutting, P. Rhys-Evans, P. Workman, K.J. Harrington, S.A. Eccles, Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck, J. Pathol. 218 (2009) 122-130.
142. K. Yonesaka, K. Zejnullahu, N. Lindeman, A.J. Homes, D.M. Jackman, F. Zhao, A.M. Rogers, B.E. Johnson, P.A. Janne, Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers, Clin. Cancer Res. 14 (2008) 6963-6973.
143. I.D. O'Neill, Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene, Lung Cancer 64 (2009) 129-130.
144. M.H. Chang, H.K. Ahn, J. Lee, C.K. Jung, Y.L. Choi, Y.H. Park, J.S. Ahn, K. Park, M.J. Ahn, Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors, Cancer 117 (2011) 143-151.
145. M.A. Vollebergh, I. Kappers, H.M. Klomp, J.C. Buning-Kager, C.M. Korse, M. Hauptmann, K.E. de Visser, M.M. van den Heuvel, S.C. Linn, Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer, J. Thorac. Oncol. 5 (2010) 1939-1948.
146. A.B. Motoyama, N.E. Hynes, H.A. Lane, The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides, Cancer Res. 62 (2002) 3151-3158.
147. C. Oliveras-Ferraros, A. Vazquez-Martin, B. Martin-Castillo, M.C. Perez-Martinez, S. Cufi, S. Del Barco, L. Bernado, J. Brunet, E. Lopez-Bonet, J.A. Menendez, Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin), Int. J. Oncol. 37 (2010) 669-678.
148. L. Ferrer-Soler, A. Vazquez-Martin, J. Brunet, J.A. Menendez, R. De Llorens, R. Colomer, An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review), Int. J. Mol. Med. 20 (2007) 3-10.
149. C. Li, M. Iida, E.F. Dunn, A.J. Ghia, D.L. Wheeler, Nuclear EGFR contributes to acquired resistance to cetuximab, Oncogene 28 (2009) 3801-3813.
150. S. Kakiuchi, Y. Daigo, N. Ishikawa, C. Furukawa, T. Tsunoda, S. Yano, K. Nakagawa, T. Tsuruo, N. Kohno, M. Fukuoka, S. Sone, Y. Nakamura, Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839), Hum. Mol. Genet. 13 (2004) 3029-3043.
151. F.R. Hirsch, S. Witta, Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer, Curr. Opin. Oncol. 17 (2005) 118-122.
152. B. Busser, L. Sancey, V. Josserand, C. Niang, M.C. Favrot, J.L. Coll, A. Hurbin, Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers, Mol. Ther. 18 (2010) 528-535.
153. B. Busser, L. Sancey, V. Josserand, C. Niang, S. Khochbin, M.C. Favrot, J.L. Coll, A. Hurbin, Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation, Mol. Ther. 18 (2010) 536-543.
154. H. Hurbin, M. Wislez, B. Busser, M. Antoine, C. Tenaud, N. Rabbe, S. Dufort, F. De Fraipont, D. Moro-Sibilot, J. Cadranel, J. Coll, E. Brambilla, Insulin-like Growth Factor-1 Receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma, J Pathol. 2011 Mar 14. doi:10.1002/path.2897. [Epub ahead of print].
155. F. Yotsumoto, H. Yagi, S.O. Suzuki, E. Oki, H. Tsujioka, T. Hachisuga, K. Sonoda, T. Kawarabayashi, E. Mekada, S. Miyamoto, Validation of HB-EGF and amphiregulin as targets for human cancer therapy, Biochem. Biophys. Res. Commun. 365 (2008) 555-561.
156. M. Piepkorn, C. Lo, G. Plowman, Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans, J. Cell. Physiol. 159 (1994) 114-120.
157. P.A. Kenny, M.J. Bissell, Targeting TACE-dependent EGFR ligand shedding in breast cancer, J. Clin. Invest. 117 (2007) 337-345.
158. J.N. Kyula, S. Van Schaeybroeck, J. Doherty, C.S. Fenning, D.B. Longley, P.G. Johnston, Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer, Clin. Cancer Res. 16 (2010) 3378-3389.
159. A. De Luca, M.P. Selvam, C. Sandomenico, S. Pepe, A.R. Bianco, F. Ciardiello, D.S. Salomon, N. Normanno, Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional antitumor drugs in human colon-cancer cells, Int. J. Cancer 73 (1997) 277-282.
160. F. Yotsumoto, T. Fukami, H. Yagi, A. Funakoshi, T. Yoshizato, M. Kuroki, S. Miyamoto, Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer, Cancer Sci. 101 (2010) 2351-2360.
161. N. Puri, R. Salgia, Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer, J Carcinog 7 (2008) 9.
162. J.M. Ricono, M. Huang, L.A. Barnes, S.K. Lau, S.M. Weis, D.D. Schlaepfer, S.K. Hanks, D.A. Cheresh, Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis, Cancer Res. 69 (2009) 1383-1391.
163. S.M. Thomas, N.E. Bhola, Q. Zhang, S.C. Contrucci, A.L. Wentzel, M.L. Freilino, W.E. Gooding, J.M. Siegfried, D.C. Chan, J.R. Grandis, Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma, Cancer Res. 66 (2006) 11831-11839.
164. A.G. Recchia, A.M. Musti, M. Lanzino, M.L. Panno, E. Turano, R. Zumpano, A. Belfiore, S. Ando, M. Maggiolini, A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells, Int. J. Biochem. Cell Biol. 41 (2009) 603-614.
165. Y. Saito, J. Haendeler, Y. Hojo, K. Yamamoto, B.C. Berk, Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation, Mol. Cell. Biol. 21 (2001) 6387-6394.
166. F. Morgillo, J.K. Woo, E.S. Kim, W.K. Hong, H.Y. Lee, Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib, Cancer Res. 66 (2006) 10100-10111.
167. N. Akutsu, Y. Bastien, R. Lin, S. Mader, J.H. White, Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma, Biochem. Biophys. Res. Commun. 281 (2001) 1051-1056.
168. C.D. Woodworth, E. McMullin, M. Iglesias, G.D. Plowman, Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2840-2844.
169. K.L. Bennett, G.D. Plowman, S.D. Buckley, J. Skonier, A.F. Purchio, Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549, Growth Factors 7 (1992) 207-213.
170. S. Tsutsui, Y. Shinomura, S. Higashiyama, Y. Higashimoto, Y. Miyazaki, S. Kanayama, S. Hiraoka, T. Minami, S. Kitamura, Y. Murayama, J. Miyagawa, N. Taniguchi, Y. Matsuzawa, Induction of heparin binding epidermal growth factor-like growth factor and amphiregulin mRNAs by gastrin in the rat stomach, Biochem. Biophys. Res. Commun. 235 (1997) 520-523.
171. Q. Zhang, S.M. Thomas, V.W. Lui, S. Xi, J.M. Siegfried, H. Fan, T.E. Smithgall, G.B. Mills, J.R. Grandis, Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation, Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6901-6906.
172. J. Shao, G.G. Sheng, R.C. Mifflin, D.W. Powell, H. Sheng, Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis, Cancer Res. 66 (2006) 846-855.
173. I. Sehgal, J. Bailey, K. Hitzemann, M.R. Pittelkow, N.J. Maihle, Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells, Mol. Biol. Cell 5 (1994) 339-347.
174. S.W. Curtis, J. Clark, P. Myers, K.S. Korach, Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus, Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 3646-3651.
175. A. Khatua, X. Wang, T. Ding, Q. Zhang, J. Reese, F.J. DeMayo, B.C. Paria, Indian hedgehog, but not histidine decarboxylase or amphiregulin, is a progesterone-regulated uterine gene in hamsters, Endocrinology 147 (2006) 4079-4092.
176. J.I. Huh, T.H. Qiu, G.V. Chandramouli, R. Charles, M. Wiench, G.L. Hager, R. Catena, A. Calvo, T.M. LaVallee, P.Y. Desprez, J.E. Green, 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice, Endocrinology 148 (2007) 1266-1277.
177. H.L. LaMarca, J.M. Rosen, Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage, Breast Cancer Res. 9 (2007) 304.
178. I. Martinez-Lacaci, M. Saceda, G.D. Plowman, G.R. Johnson, N. Normanno, D.S. Salomon, R.B. Dickson, Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines, Endocrinology 136 (1995) 3983-3992.
179. H. Negishi, C. Ikeda, Y. Nagai, A. Satoh, Y. Kumasako, S. Makinoda, T. Ustunomiya, Regulation of amphiregulin. EGFR-like factor expression by hCG in cultured human granulosa cells, Acta Obstet. Gynecol. Scand. 86 (2007) 706-710.
180. C.C. Johansson, A. Yndestad, J.M. Enserink, A.H. Ree, P. Aukrust, K. Tasken, The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3′,5′-monophosphate pathway in various cell types, Endocrinology 145 (2004) 5177-5184.
181. D. Ornskov, E. Nexo, B.S. Sorensen, Insulin induces a transcriptional activation of epiregulin, HB-EGF and amphiregulin, by a PI3K-dependent mechanism: identification of a specific insulin-responsive promoter element, Biochem. Biophys. Res. Commun. 354 (2007) 885-891.
182. D.A. Vardy, C. Kari, G.S. Lazarus, P.J. Jensen, A. Zilberstein, G.D. Plowman, U. Rodeck, Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1, J. Cell. Physiol. 163 (1995) 257-265.
183. Y. Miyazaki, Y. Shinomura, S. Tsutsui, Y. Yasunaga, S. Zushi, S. Higashiyama, N. Taniguchi, Y. Matsuzawa, Oxidative stress increases gene expression of heparin-binding EGF-like growth factor and amphiregulin in cultured rat gastric epithelial cells, Biochem. Biophys. Res. Commun. 226 (1996) 542-546.
184. K. Horiuchi, S. Le Gall, M. Schulte, T. Yamaguchi, K. Reiss, G. Murphy, Y. Toyama, D. Hartmann, P. Saftig, C.P. Blobel, Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx, Mol. Biol. Cell 18 (2007) 176-188.
185. S. Blanchet, K. Ramgolam, A. Baulig, F. Marano, A. Baeza-Squiban, Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells, Am. J. Respir. Cell Mol. Biol. 30 (2004) 421-427.
186. M. Rumelhard, K. Ramgolam, F. Auger, A.C. Dazy, S. Blanchet, F. Marano, A. Baeza-Squiban, Effects of PM2.5 components in the release of amphiregulin by human airway epithelial cells, Toxicol. Lett. 168 (2007) 155-164.
187. S.S. Choi, M.A. Miller, P.A. Harper, In utero exposure to 2,3,7,8-tetrachlorodi-benzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter, Toxicol. Sci. 94 (2006) 163-174.
188. B. Du, N.K. Altorki, L. Kopelovich, K. Subbaramaiah, A.J. Dannenberg, Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism, Cancer Res. 65 (2005) 5982-5988.
189. H. Lemjabbar, D. Li, M. Gallup, S. Sidhu, E. Drori, C. Basbaum, Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin, J. Biol. Chem. 278 (2003) 26202-26207.
190. M. Vecchi, L.A. Rudolph-Owen, C.L. Brown, P.J. Dempsey, G. Carpenter, Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin, J. Biol. Chem. 273 (1998) 20589-20595.
191. N. Normanno, N. Kim, D. Wen, K. Smith, A.L. Harris, G. Plowman, G. Colletta, F. Ciardiello, D.S. Salomon, Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas, Breast Cancer Res. Treat. 35 (1995) 293-297.
192. B. Busser, J.L. Coll, A. Hurbin, The increasing role of amphiregulin in non-small cell lung cancer, Pathol Biol (Paris) 57 (2009) 511-512.
193. P.W. Cook, M.R. Pittelkow, W.W. Keeble, R. Graves-Deal, R.J. Coffey Jr., G.D. Shipley, Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas, Cancer Res. 52 (1992) 3224-3227.
194. T. Oikawa, J. Hitomi, A. Kono, E. Kaneko, K. Yamaguchi, Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells, Int. J. Pancreatol. 18 (1995) 15-23.
195. E.M. Bindels, T.H. van der Kwast, V. Izadifar, D.K. Chopin, W.I. de Boer, Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2, Urol. Res. 30 (2002) 240-247.
196. D.E. Hansel, A. Rahman, M. Hidalgo, P.J. Thuluvath, K.D. Lillemoe, R. Shulick, J.L. Ku, J.G. Park, K. Miyazaki, R. Ashfaq, I.I. Wistuba, R. Varma, L. Hawthorne, J. Geradts, P. Argani, A. Maitra, Identification of novel cellular targets in biliary tract cancers using global gene expression technology, Am. J. Pathol. 163 (2003) 217-229.
197. S.D. Billings, M.D. Southall, T. Li, P.W. Cook, L. Baldridge, W.B. Moores, D.F. Spandau, J.G. Foley, J.B. Travers, Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma, Am. J. Pathol. 163 (2003) 2451-2458.
198. O.C. P, P. Rhys-Evans, S. Eccles, Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells, Int. J. Cancer 88 (2000) 759-765.
199. T. Yamamoto, I. Fujita, T. Akisue, T. Marui, T. Nakatani, T. Kawamoto, T. Hitora, K. Nagira, K. Matsumoto, M. Kurosaka, Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues, Anticancer Res. 24 (2004) 1307-1310.
200. K. Mahtouk, D. Hose, T. Reme, J. De Vos, M. Jourdan, J. Moreaux, G. Fiol, M. Raab, E. Jourdan, V. Grau, M. Moos, H. Goldschmidt, M. Baudard, J.F. Rossi, F.W. Cremer, B. Klein, Expression of EGF-family receptors and amphiregulin in multiple myeloma, Amphiregulin is a growth factor for myeloma cells, Oncogene 24 (2005) 3512-3524.